Evidence map›Paper›PMID 41745664›Full record

ArticleSports (Basel, Switzerland)2026

Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training Stimulus.

Polyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Despina Fotiou, Pantelis Rousakis, Chrysanthi Panteli and 6 more

Abstract read
In one paragraph

Article in Sports (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Polyxeni SpiliopoulouSports Performance Laboratory, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0003-4951-3563
Evangelos Eleutherakis-PapaiakovouDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0003-3407-5994
Magdalini MigkouDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0003-0131-2447
Nikolaos KanelliasDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-1935-5069
Ioannis Ntanasis-StathopoulosDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-6328-9783
Panagiotis MalandrakisDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-4673-171X
Foteini TheodorakakouDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0001-6926-0351
Despina FotiouDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-0618-8900
Pantelis RousakisFlow Cytometry Unit, Department of Biology, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0003-3853-4043
Chrysanthi PanteliFlow Cytometry Unit, Department of Biology, National and Kapodistrian University of Athens, 17237 Athens, Greece.
Evangelos TerposDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0001-5133-1422
Maria GavriatopoulouDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-6244-1229
Ourania E TsitsilonisFlow Cytometry Unit, Department of Biology, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0001-6954-0740
Efstathios KastritisDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0001-8191-5832
Meletios Athanasios DimopoulosDepartment of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0001-8990-3254
Gerasimos TerzisSports Performance Laboratory, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, 17237 Athens, Greece.ORCID 0000-0002-0049-5395

Funding

Stavros Tsakyrakis Scholarships 16257
6 · The paper itself

Abstract

backgroundPrevious studies have reported no improvements in quality of life or physical function following exercise training in patients with multiple myeloma, without a clear explanation. The purpose of the present study was to examine the effects of an exercise-training intervention on these outcomes and to determine whether the observed results could be explained by the characteristics of the training program.

methodsSixteen patients with multiple myeloma who had completed first-line induction therapy were assigned to two groups. One group (2 men, 6 women, 52.6 ± 10.3 years) commenced maintenance therapy only, while the other group (2 men, 6 women, 58.8 ± 7.1 years) initiated maintenance therapy combined with a supervised exercise training program conducted twice per week. Each exercise session included 30 min of cycling and seven resistance exercises targeting the major muscle groups. The intervention lasted 4.4 ± 1 months. QoL, the six-minute walking test, handgrip strength, maximal aerobic power, maximum isometric contraction across 14 positions, and bone density were assessed before and after the intervention.

resultsThe six-minute walking test distance significantly increased in the exercise group (9.36 ± 6.88%,

conclusionsThe progression of the training stimulus appears to be inconsistent in this specific population, potentially limiting improvements in quality of life and physical function outcomes. Supervision appears to be necessary for exercise training in patients with multiple myeloma. Future research should investigate alternative exercise modalities in these patients.

Indexed as

bone densityexercise traininghandgrip strengthmultiple myelomaphysical functionquality of life

Identifiers

PMID41745664
PMCPMC12945274

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.